Therapeutic Classification: antianginals, antihypertensives
Pharmacologic Classification: calcium channel blockers
BEERS REMS
Absorption: Well absorbed after oral administration, but large amounts are rapidly metabolized, resulting in ↓ bioavailability (4570%); bioavailability is ↑ (80%) with extended-release forms.
Distribution: Unknown.
Protein Binding: 9298%.
Half-Life: 25 hr.
Contraindicated in:
Use Cautiously in:
CV: peripheral edema, bradycardia, chest pain, HF, hypotension, palpitations, syncope, tachycardia
Derm: flushing, ↑sweating, dermatitis, erythema multiforme, photosensitivity, pruritus/urticaria, rash, STEVENS-JOHNSON SYNDROME
EENT: blurred vision, disturbed equilibrium, epistaxis, tinnitus
Endo: gynecomastia, hyperglycemia
GI: ↑liver enzymes, GI obstruction, anorexia, constipation, diarrhea, dry mouth, dyspepsia, nausea, vomiting
GU: dysuria, nocturia, polyuria, sexual dysfunction, urinary frequency
Hemat: anemia, leukopenia, thrombocytopenia
MS: joint stiffness, muscle cramps
Neuro: paresthesia, tremor
Resp: cough, dyspnea, shortness of breath
Misc: gingival hyperplasia
Drug-drug:
Drug-Natural Products:
Lab Test Considerations:
NDC Code